Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members

AIDS

Volumn 19, Issue 10, 2005, Pages 1035-1042

  Mermin, Jonathan ^a   Lule, John ^a   Ekwaru, John Paul ^a   Downing, Robert ^a   Hughes, Peter ^a,b   Bunnell, Rebecca ^a   Malamba, Samuel ^a   Ransom, Ray ^a   Kaharuza, Frank ^a   Coutinho, Alex ^b   Kigozi, Aminah ^a   Quick, Robert ^c  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b THE AIDS SUPPORT ORGANIZATION   (Uganda)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Africa; Cotrimoxazole; Diarrhea; Family; HIV; Malaria; Mortality; Resistance

Indexed keywords

COTRIMOXAZOLE;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RURAL AREA; UGANDA;

EID: 21844447397     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000174449.32756.c7     Document Type: Article

References (22)

1. Wiktor SZ, Sassan MM, Grant AD, Abouya L, Karon JM, Maurice C, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 1999; 353:1469-1475.
2. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, et al. Effect of cotrimoxazole prophylaxis on morbidity, mortality, CD4 cell count, and HIV viral load among persons with HIV in rural Uganda. Lancet 2004; 364:1428-1434.
3. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 2004; 364:1865-1871.
4. Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 1999; 353:1463-1468.
5. WHO, UNAIDS. Provisional WHO/UNAIDS Secretariat Recommendations on the use of Cotrimoxazole Prophylaxis in adults and children living with HIV/AIDS in Africa. 2000 and 2004. http://www.unaids.org/
6. Brou H, Desgrees-du-Lou A, Souville M, Moatti JP, Msellati P. Prophylactic use of cotrimoxazole against opportunistic infections in HIV-positive patients: knowledge and practices of health care providers in Cote d'Ivoire. AIDS Care 2003; 15:629-637.
7. Grimwade K, Gilks C. Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries. Curr Opin Infect Dis 2001; 14:507-512.
8. Boeree MJ, Harries AD, Zijlstra EE, Taylor TE, Molyneu ME. Co-trimoxazole in HIV-1 infection. Lancet 1999; 354:333-334.
9. Whitty CJ, Jaffar S. Plasmodium falciparum cross resistance. Lancet 2002; 359:80.
10. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000; 356:1051-1056.
11. Buchwald DS, Blaser M. A Review of human Salmonellosis: II. Duration of excretion following infection with Nontyphi Salmonella. Review of Infectious Diseases 1984; 6:345-356.
12. Reisen WK, Aslamkhan M. A release-recapture experiment with the malaria vector, Anopheles stephensi Liston, with observations on dispersal, survivorship, population size, gonotrophic rhythm and mating behaviour. Ann Trop Med Parasitol 1979; 73:251-269.
13. Cho SH, Lee HW, Shin EH, Lee HI, Lee WG, Kim CH, et al. A mark-release-recapture experiment with Anopheles sinensis in the northern part of Gyeonggi-do, Korea. Korean J Parasitol 2002; 40:139-148.
14. Michael E, Ramaiah KD, Hoti SL, Barker G, Paul MR, Yuvaraj J, et al. Quantifying mosquito biting patterns on humans by DNA fingerprinting of bloodmeals. Am J Trop Med Hygiene 2001; 65:722-728.
15. Nduati R, Richardson BA, John G, Mbori-Ngacha D, Mwatha A, Ndinya-Achola J, et al. Effect of breasfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet 2001; 357:1651-1655.
16. El-Channam AR. The global problems of child malnutrition and mortality in different world regions. J Health Soc Policy 2003; 16:1-26.
17. Doctor HV, Weinreb AA. Estimation of AIDS adult mortality by verbal autopsy in rural Malawi. AIDS 2003; 17:2509-2513.
18. Kamali A, Wagner HU, Nakiyingi J, Sabiiti I, Kengeya-Kayondo JF, Mulder DW. Verbal autopsy as a tool for diagnosing HIV-related adult deaths in rural Uganda. Int J Epidemiol 1996; 25:679-684.
19. Anglaret X. Trimethoprim-sulfamethoxazole prophylaxis in sub-Saharan Africa. Lancet 2001; 358:1027-1028.
20. Chandramohan D, Maude G, Rodrigues LC, Hayes RJ. Verbal autopsies for adult deaths: issues in their development and validation. Int J Epidemiol 1994; 23:213-222.
21. Kaplan JE, Masur H, Holmes KK. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among HIV-infected persons. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR 2002. 51(No. RR-8):2002.
22. McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS 1999; 13:1687-1695.